UBS/CALL/ROCHE GS/450.004/0.025/19.12.25 Share Price

Warrant

CROGSU

CH1147777259

Delayed Swiss Exchange 09:50:00 15/11/2023 pm IST
0.032 CHF -3.03% Intraday chart for UBS/CALL/ROCHE GS/450.004/0.025/19.12.25
6 months-54.93%

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
CROGSU
ISINCH1147777259
Date issued 16/12/2021
Strike 450 CHF
Maturity 19/12/2025 (579 Days)
Parity 40 : 1
Emission price 0.6 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.76 CHF
Lowest since issue 0.032 CHF
Delta0.04x
Omega 7.925
Premium90.29x
Gearing200.93x
Moneyness 0.5269
Difference Strike 212.9 CHF
Difference Strike %+47.31%
Spread 0.019 CHF
Spread %48.72%
Theoretical value 0.0295
Implied Volatility 27.40 %
Total Loss Probability 98.21 %
Intrinsic value 0.000000
Present value 0.0295
Break even 451.18 CHF
Theta-0x
Vega0.01x
Rho0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
  1. Stock Market
  2. Warrants
  3. CROGSU Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW